Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 61-72 of 2,031
Drug study icon
RecruitingISRCTN31103960

MSP-1014.OX for depression

This study is recruiting in the United Kingdom. OX for depression.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Clerkenwell Health
Condition
Depression
Drug study icon
RecruitingNCT06775379

A Study of Azetukalner Versus Placebo in Major Depressive Disorder

This study is recruiting in the United States. It is testing azetukalner for depression.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Depression
Device study icon
RecruitingNCT05913960

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway

This study is looking at whether sham stimulation can help people with depression or depression, Recurrent. Participants take part in sham stimulation and complete follow-up assessments.

In Hangzhou
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 45 Years
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Condition
Depression
Behavioral study icon
RecruitingNCT05630963

Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Belmont
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 45 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
Device study icon
RecruitingNCT04004169

Closed-Loop Deep Brain Stimulation for Major Depression

This study is looking at test a personalized approach to brain stimulation as an intervention for depression. Participants take part in a digital support tool and complete follow-up assessments.

In San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Andrew Krystal
Condition
Depression
Behavioral study icon
RecruitingNCT06439043

Cultural Adaptation of EMDR for Major Depressive Disorder and Compaire Its Online and Face-to-Face Testing

This study is looking at whether cognitive behavioural therapy can help people with depression 1. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In Kohat
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 20 Years to 50 Years
Countries
Pakistan
Sponsor
Khushal Khan Khattak Univeristy, Karak, Pakistan
Condition
Depression
Drug study icon
RecruitingISRCTN28327843

Early effect of agomelatine on general interest in outpatients suffering major depressive disorder

This study is testing a medication approach for people with Depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Romania
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Romania
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
Other study type icon
RecruitingISRCTN44737909

Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in people with major depressive disorder: a six-week parallel group study versus comparator, followed by a optional treatment extension period up to six months

This study is recruiting in Australia, in France, in the United Kingdom, .... It focuses on depression.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Australia, France, United Kingdom, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
Other study type icon
RecruitingISRCTN49376288

Efficacy of agomelatine given orally on rest/activity circadian rhythms in outpatients with major depressive disorder: a international study with parallel groups versus Selective Serotonin Reuptake Inhibitor (SSRI). Six-week treatment plus optional continuation for 18 weeks.

This study is recruiting in France, in Austria, in Germany, .... It focuses on depression.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 60 Years
Countries
France, Austria, Germany, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.